Toward precision medicine based on the molecular landscape of carcinoma in situ of the bronchus: is it realistic for patients with pre-invasive lung disease?

Early detection of cancer, particularly through screening of high-risk patients, is essential to decreasing the mortality due to cancer, notably lung cancer (1). Early detection is made possible by sampling of cytological and/or histological specimens that provide a diagnosis of the precancerous lesion.